SunText Reviews

Article Type : Short commentary

Clinical Trials of Novel Perspectives on Semaglutide with Injectable and Oral Formulations

Authors : Bando H

DOI : 10.51737/2771-5469.2022.007

Keywords : Semaglutide Unabated Sustainability in Treatment of Type 2 Diabetes (SUSTAIN); Peptide Innovation for Early Diabetes Treatment (PIONEER); Semaglutide Treatment Effect in People with Obesity (STEP); Sodium N-(8-[2-hydroxybenzoyl] amino) caprylate (SNAC); Rybelsus

PDF Full Text DOI

Article Type : Short commentary

Effective Treatment for Type 2 Diabetes (T2D) by Imeglimin (Twymeeg) and Vildagliptin/Metformin (EquMet)

Authors : Bando H, Kato Y, Yamashita H, Kato Y and Kawata T

DOI : 10.51737/2771-5469.2023.008

Keywords : Oral hypoglycemic agents (OHAs); Imeglimin (Twymeeg); Vildagliptin/Metformin (EquMet); Trials of IMeglimin for Efficacy and Safety (TIMES); Vildagliptin Efficacy in combination with metfoRmIn For early treatment of type 2 diabetes (VERIFY)

PDF Full Text DOI

Article Type : Short commentary

Improvement of Obesity and Type 2 Diabetes (T2D) by Oral Semaglutide (Rybelsus) and Super-Low Carbohydrate Diet (LCD)

Authors : Bando H, Iwatsuki N, Okada M, Ogawa T and Sakamoto K

DOI : 10.51737/2771-5469.2023.010

Keywords : Super-low carbohydrate diet (LCD); Oral semaglutide (Rybelsus); Glucagon-like-peptide 1 receptor agonist (GLP1-RA); Sodium N-(8-[2-hydroxybenzoyl] amino) caprylate (SNAC); Peptide InnOvatioN for Early diabEtes tReatment (PIONEER)

PDF Full Text DOI

Article Type : Short commentary

Improved Glucose Variability by Imeglimin (Twymeeg) After Hypoglycemic Episode in T2D Patient

Authors : Bando H, Ogawa H, Kobayashi H, Nagahiro S, Nakanishi S and Watanabe O

DOI : 10.51737/2771-5469.2023.009

Keywords : Imeglimin (Twymeeg); Glubes (mitiglinide/voglibose); EquMet (Vildagliptin/Metformin); Trials of IMeglimin for Efficacy and Safety (TIMES); Oral hypoglycemic agent (OHA)

PDF Full Text DOI

Article Type : Short commentary

Rapid Decrease of HbA1c by Imeglimin (Twymeeg) in Patient with Obesity and Type 2 Diabetes (T2D)

Authors : Bando H, Kato Y, Yamashita H, Kato Y and Ogura K

DOI : 10.51737/2771-5469.2023.011

Keywords : Low carbohydrate diet (LCD); Imeglimin (Twymeeg); Oral hypoglycemic agents (OHAs); Trials of IMeglimin for Efficacy and Safety (TIMES); Japan LCD promotion association (JLCDPA)

PDF Full Text DOI

Article Type : Case Report

Clinical Perspectives of Luseogliflozin and Vildagliptin/Metformin (EquMet) in Patients with Type 2 Diabetes (T2D) and Renal Stone

Authors : Bando M, Hayami E, Abe H, Little M, Taiji M, Nishitani N and Bando H

DOI : 10.51737/2771-5469.2023.012

Keywords : Atherosclerotic cardiovascular accident (ASCVD); Vildagliptin Efficacy in combination with metfoRmIn for early treatment of type 2 diabetes (VERIFY) vildagliptin/metformin (EquMet); Sodium-glucose co-transporter-2 inhibitor (SGLT2-i); Uric acid (UA)

PDF Full Text DOI

Article Type : Short commentary

Development of Type 2 diabetes (T2D) with Remarkable Weight Gain Treated by Imeglimin (Twymeeg)

Authors : Bando H, Okada M, Iwatsuki N, Ogawa T, Sakamoto K

DOI : 10.51737/2771-5469.2023.013

Keywords : Weight gain; Vildagliptin/metformin (EquMet); Low carbohydrate diet (LCD); Japan LCD promotion association (JLCDPA); Trials of IMeglimin for Efficacy and Safety (TIMES)

PDF Full Text DOI

Article Type : Short commentary

Latest Trends for Type 2 Diabetes (T2D) from Bio-Psycho-Social Points of View

Authors : Bando H

DOI : 10.51737/2771-5469.2023.014

Keywords : Cognitive Behavioral Therapy (CBT); Gut-brain-microbiota axis (MGBA); Social Determinants of Health (SDOH); Montreal Cognitive Assessment (MOCA); Hinoharaism

PDF Full Text DOI

Article Type : Short commentary

Stable Glucose Variability in a Patient with Slowly Progressive Type 1 Insulin-Dependent Diabetes Mellitus (SPIDDM) with Low-Carbohydrate Diet (LCD)

Authors : Wood M, Ebe K and Bando H

DOI : 10.51737/2771-5469.2024.015

Keywords : Slowly progressive type 1 insulin-dependent diabetes mellitus (SPIDDM); Low-Carbohydrate Diet (LCD); Glutamic acid decarboxylase (GAD); Ketone bodies (KB); 3-hydroxybutyric acid (3-HB)

PDF Full Text DOI

Article Type : Case Report

Effective Imeglimin (Twymeeg) Treatment for Diabetic Patient with Various Medical Problems

Authors : Kobayashi T, Bando H, Okada M, Iwatsuki N, Ogawa T and Sakamoto K

DOI : 10.51737/2771-5469.2024.016

Keywords : Imeglimin (Twymeeg); Androgenetic alopecia (AGA); Dutasteride; Gastrointestinal adverse effect (GIAE); Japan LCD promotion association (JLCDPA)

PDF Full Text DOI

Article Type : Case Report

Body Composition of Preserved Muscle, Water Balance and Phase Angle in 90-Year-Old Chemist with Regular Lifestyle

Authors : Shimamura T* and Bando H

DOI : 10.51737/2771-5469.2024.017

Keywords : New Elderly Association (NEA); Bioelectrical Impedance Analyses (BIA); Extracellular Water/Total Body Water (ECW/TBW); Body Composition Analysis; Phase Angle (PhA); InBody

PDF Full Text DOI

Article Type : Research Article

Role of Low-Carbohydrate Diets in Diabetes Management

Authors : Wood M, Ebe K and Bando H

DOI : 10.51737/2771-5469.2024.018

Keywords : Glycemic control; Low carbohydrate diet (LCD); Calorie-restricted diet (CRD); Japan LCD Promotion Association (JLCDPA)

PDF Full Text DOI

Article Type : Short commentary

Adherence to Medical and Dietary Therapy in Type 2 Diabetes Patients

Authors : Wood M, Ebe K and Bando H

DOI : 10.51737/2771-5469.2024.019

Keywords : Japan LCD Promotion Association (JLCDPA); Non-Adherence; Healthcare System; Polypharmacy; Nutrition; Low-carbohydrate diet (LCD)

PDF Full Text DOI

Article Type : Case Report

Remarkable Effects for HbA1c and Weight by Twymeeg (imeglimin) and EquMet in Type 2 Diabetes (T2D) Patient

Authors : Ogawa T, Bando H, Iwatsuki N, Okada M and Sakamoto K

DOI : 10.51737/2771-5469.2024.020

Keywords : Imeglimin (Twymeeg); Trials of IMeglimin for Efficacy and Safety (TIMES); vildagliptin/metformin (EquMet); Low Carbohydrate Diet (LCD); Japan LCD promotion association (JLCDPA)

PDF Full Text DOI

SunText Review of Endocrine Care

ISSN: 2771-5469

Clinical Trials of Novel Perspectives on Semaglutide with Injectable and Oral Formulations

Keywords : Semaglutide Unabated Sustainability in Treatment of Type 2 Diabetes (SUSTAIN); Peptide Innovation for Early Diabetes Treatment (PIONEER); Semaglutide Treatment Effect in People with Obesity (STEP); Sodium N-(8-[2-hydroxybenzoyl] amino) caprylate (SNAC); Rybelsus

Effective Treatment for Type 2 Diabetes (T2D) by Imeglimin (Twymeeg) and Vildagliptin/Metformin (EquMet)

Keywords : Oral hypoglycemic agents (OHAs); Imeglimin (Twymeeg); Vildagliptin/Metformin (EquMet); Trials of IMeglimin for Efficacy and Safety (TIMES); Vildagliptin Efficacy in combination with metfoRmIn For early treatment of type 2 diabetes (VERIFY)

Improvement of Obesity and Type 2 Diabetes (T2D) by Oral Semaglutide (Rybelsus) and Super-Low Carbohydrate Diet (LCD)

Keywords : Super-low carbohydrate diet (LCD); Oral semaglutide (Rybelsus); Glucagon-like-peptide 1 receptor agonist (GLP1-RA); Sodium N-(8-[2-hydroxybenzoyl] amino) caprylate (SNAC); Peptide InnOvatioN for Early diabEtes tReatment (PIONEER)

Improved Glucose Variability by Imeglimin (Twymeeg) After Hypoglycemic Episode in T2D Patient

Keywords : Imeglimin (Twymeeg); Glubes (mitiglinide/voglibose); EquMet (Vildagliptin/Metformin); Trials of IMeglimin for Efficacy and Safety (TIMES); Oral hypoglycemic agent (OHA)

Rapid Decrease of HbA1c by Imeglimin (Twymeeg) in Patient with Obesity and Type 2 Diabetes (T2D)

Keywords : Low carbohydrate diet (LCD); Imeglimin (Twymeeg); Oral hypoglycemic agents (OHAs); Trials of IMeglimin for Efficacy and Safety (TIMES); Japan LCD promotion association (JLCDPA)

Clinical Perspectives of Luseogliflozin and Vildagliptin/Metformin (EquMet) in Patients with Type 2 Diabetes (T2D) and Renal Stone

Keywords : Atherosclerotic cardiovascular accident (ASCVD); Vildagliptin Efficacy in combination with metfoRmIn for early treatment of type 2 diabetes (VERIFY) vildagliptin/metformin (EquMet); Sodium-glucose co-transporter-2 inhibitor (SGLT2-i); Uric acid (UA)

Development of Type 2 diabetes (T2D) with Remarkable Weight Gain Treated by Imeglimin (Twymeeg)

Keywords : Weight gain; Vildagliptin/metformin (EquMet); Low carbohydrate diet (LCD); Japan LCD promotion association (JLCDPA); Trials of IMeglimin for Efficacy and Safety (TIMES)

Latest Trends for Type 2 Diabetes (T2D) from Bio-Psycho-Social Points of View

Keywords : Cognitive Behavioral Therapy (CBT); Gut-brain-microbiota axis (MGBA); Social Determinants of Health (SDOH); Montreal Cognitive Assessment (MOCA); Hinoharaism

Stable Glucose Variability in a Patient with Slowly Progressive Type 1 Insulin-Dependent Diabetes Mellitus (SPIDDM) with Low-Carbohydrate Diet (LCD)

Keywords : Slowly progressive type 1 insulin-dependent diabetes mellitus (SPIDDM); Low-Carbohydrate Diet (LCD); Glutamic acid decarboxylase (GAD); Ketone bodies (KB); 3-hydroxybutyric acid (3-HB)

Effective Imeglimin (Twymeeg) Treatment for Diabetic Patient with Various Medical Problems

Keywords : Imeglimin (Twymeeg); Androgenetic alopecia (AGA); Dutasteride; Gastrointestinal adverse effect (GIAE); Japan LCD promotion association (JLCDPA)

Body Composition of Preserved Muscle, Water Balance and Phase Angle in 90-Year-Old Chemist with Regular Lifestyle

Keywords : New Elderly Association (NEA); Bioelectrical Impedance Analyses (BIA); Extracellular Water/Total Body Water (ECW/TBW); Body Composition Analysis; Phase Angle (PhA); InBody

Role of Low-Carbohydrate Diets in Diabetes Management

Keywords : Glycemic control; Low carbohydrate diet (LCD); Calorie-restricted diet (CRD); Japan LCD Promotion Association (JLCDPA)

Adherence to Medical and Dietary Therapy in Type 2 Diabetes Patients

Keywords : Japan LCD Promotion Association (JLCDPA); Non-Adherence; Healthcare System; Polypharmacy; Nutrition; Low-carbohydrate diet (LCD)

Remarkable Effects for HbA1c and Weight by Twymeeg (imeglimin) and EquMet in Type 2 Diabetes (T2D) Patient

Keywords : Imeglimin (Twymeeg); Trials of IMeglimin for Efficacy and Safety (TIMES); vildagliptin/metformin (EquMet); Low Carbohydrate Diet (LCD); Japan LCD promotion association (JLCDPA)